• ‚Äč
    • Share to Facebook
    • Twitter
    • Email
    • Print

February 24, 2014

Companies with Invasive Chimpanzee Research Policies

Over the last several years, the U.S. government and private companies worldwide have increasingly supported phasing out the use of chimpanzees in harmful research. The first major turning point came in 2011, when an Institute of Medicine report found that chimpanzee use in research is largely unnecessary and could not identify any area of current biomedical research for which chimpanzee use is essential. Since then, the National Institutes of Health has announced their intention to permanently retire nearly 90 percent of all government-owned chimpanzees to sanctuary and significantly curtail the use of chimpanzees in NIH’s government-funded research.

Many private research entities have also indicated their support for phasing out chimpanzee use by adopting policies stating that they will not conduct or financially support invasive research on chimpanzees. Others have severely restricted their use of chimpanzees by following the principles set forth by the Institute of Medicine report. The pharmaceutical companies and biotech firms listed below have adopted such policies* and are listed by size of company.

The Humane Society of the United States commends companies that have adopted policies demonstrating their commitment to chimpanzee welfare.

  • GlaxoSmithKline, PLC
    GlaxoSmithKline is a multi-billion-dollar global health care company with U.S. corporate headquarters in Pennsylvania and North Carolina and approximately 99,000 employees. The company voluntarily ended its use of chimpanzees in research in 2008 and has committed not to conduct or fund future research on great apes.

  • Merck & Co., Inc.
    Merck, headquartered in White House Station, N.J., is a multi-billion-dollar global health care company with approximately 80,000 employees. Merck has committed not to conduct or financially support biomedical research on chimpanzees now or in the foreseeable future due to available alternatives.

  • DuPont
    DuPont, headquartered in Wilmington, Del., is a multi-billion-dollar research and technology company that employs more than 70,000 people worldwide and operates in more than 90 countries. DuPont develops and markets a wide range of products, including pharmaceutical ingredients. The company has committed not to conduct or contract invasive research on great apes.

  • AstraZeneca, PLC
    AstraZeneca is a multi-billion-dollar global biopharmaceutical company with a U.S. subsidiary based in Wilmington, Del.. The company employs more than 50,000 people and markets products in more than 100 countries. AstraZeneca does not conduct or fund research on great apes and has committed to following a rigorous ethical and scientific review process if the potential need arises in the future.

  • Colgate-Palmolive Company
    Colgate-Palmolive, headquartered in New York, N.Y., is a multi-billion-dollar global consumer products company with more than 37,000 employees worldwide. The company has committed not to conduct or financially support invasive research on great apes.

  • Novo Nordisk
    Novo Nordisk, headquartered globally in Denmark and domestically in New Jersey, is a multi-billion-dollar health care company with more than 37,000 employees. Novo Nordisk does not use chimpanzees in research and supports a general ban on the use of all great ape species in research unless testing is specifically required by a regulatory authority.

  • AbbVie
    AbbVie (formerly Abbott Laboratories), headquartered in North Chicago, Ill., is a multi-billion-dollar pharmaceutical company with more than 21,000 employees worldwide. Abbvie does not currently use chimpanzees in research and does not foresee using them in the future. The company has committed to following the Institute of Medicine principles if the potential need arises in the future.

  • Amgen, Inc.
    Amgen, headquartered in Thousand Oaks, Calif., is a multi-billion-dollar pharmaceutical company with a staff of more than 20,000 people worldwide and subsidiaries in over 40 countries. Amgen does not conduct research on chimpanzees and has committed to transition to alternative models in the event the company acquires a technology or molecule that was developed using research in chimpanzees.

  • Hospira, Inc.
    Hospira, based in Lake Forest, Ill, is a global multi-billion-dollar pharmaceutical company with more than 15,000 employees worldwide. Hospira has never used chimpanzees in research and has committed to never conducting or funding any future research using great apes.

  • Grifols
    Grifols is a multi-billion-dollar global health care company based in Barcelona, Spain, with a U.S. subsidiary in Los Angeles, Calif., that employs more than 11,000 people worldwide. Grifols has never used chimpanzees in research and has committed not to conduct or financially support any research that uses great apes.

  • H. Lundbeck A/S
    Lundbeck is a multi-billion-dollar global pharmaceutical company with a U.S. subsidiary in Deerfield, Ill. The company employs approximately 5,800 people in 57 countries and offers products in more than 100 countries. Lundbeck has committed not to conduct research on great apes.

  • Gilead Sciences, Inc.
    Gilead, headquartered in Foster City, Calif., is a multi-billion-dollar biopharmaceutical company employing more than 5,300 individuals globally. Gilead has committed not to conduct or financially support research on chimpanzees.

  • Forest Laboratories, Inc.
    Forest Laboratories, headquartered in New York, N.Y., is a multi-billion-dollar pharmaceutical company with more than 5,000 employees. Forest Laboratories does not currently conduct research on chimpanzees and has committed not to conduct or financially support research on any great ape species in the future.

  • Endo Health Solutions, Inc.
    Endo Health Solutions, headquartered in Malvern, Pa., is a multi-billion-dollar health care company with approximately 4,600 employees and develops generic and branded pharmaceuticals under its subsidiary, Endo Pharmaceuticals. Endo has never used chimpanzees in research and has committed not to conduct or financially support research on great apes.

  • Actelion Pharmaceuticals, Ltd.
    Actelion is a biopharmaceutical company that employs more than 2,400 individuals and markets products in more than 30 countries. The company’s global headquarters is based in Basel, Switzerland, with a U.S. affiliate based in South San Francisco, Calif. Actelion has never used chimpanzees in research and has an internal animal welfare policy which prohibits the use of all great ape species in research.

  • Idenix Pharmaceuticals, Inc.
    Idenix, headquartered in Cambridge, Mass., is a multi-million-dollar pharmaceutical company. Idenix does not currently conduct research on chimpanzees and has committed not to conduct or financially support future research on great apes.

  • Phoenix Pharmaceuticals, Inc.
    Phoenix Pharmaceuticals, headquartered in Burlingame, Calif., is a privately held pharmaceutical company with global subsidiaries and distributors. Phoenix Pharmaceuticals has never used chimpanzees for research and has committed not to conduct or financially support invasive research on great apes.

  • QED Biosciences, Inc.
    QED Biosciences, headquartered in San Diego, Calif., is a multi-million-dollar research company that has committed not to conduct or fund invasive research on great apes.

  • Genesis Laboratories, Inc.
    Genesis Laboratories, headquartered in Wellington, Colo., is an independent research company that conducts regulatory and toxicology research. Genesis Laboratories has committed not to conduct or financially support invasive research on great apes.

  • Best American Toxicology Testing Services (BATTS), LLC.
    BATTS is a U.S.-based independent toxicology and regulatory consulting laboratory located in Southern California. BATTS conducts preclinical drug, pharmacokinetic, and preclinical efficacy studies for many biotech industries including pharmaceutical companies. BATTS has committed not to conduct or financially support invasive research and testing on chimpanzees.

  • Excel Bio-Products, Inc.
    Excel Bio-Products, located in Washburn, Mo., is a small, privately owned pharmaceutical and medicine manufacturing company specializing in the production of polyclonal antibodies. Excel has never used chimpanzees in research and has committed not to conduct or financially support research in great apes.

  • Panigen, Inc.
    Panigen is a privately-owned, U.S.-based research company located in Wisconsin. Panigen does not currently conduct research on any primate species and has committed never to conduct or financially support research on great apes.

* Five additional companies that wish to remain anonymous have also adopted internal policies not to conduct or financially support invasive research on great apes.


Learn more about animals used in experiments at
humanesociety.org/animalsinlaboratories

  • Sign Up
  • Log in using one of your preferred sites
    Login Failure
  • Take Action
  • Ten things you can do to help animals suffering in labs Take action

  • Shop